Paper8553070
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1.
Hahn SA and 10 others. Science, 1996. Cited by 2,111 papers, by iCite.
Cite this record
ConductScience Library. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Papers, record 8553070. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8553070
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Chromosomes, Human, Pair 18 | Major topic |
| DNA-Binding Proteins | Major topic |
| Genes, Tumor Suppressor | Major topic |
| Pancreatic Neoplasms | Major topic |
| Proteins | Major topic |
| Trans-Activators | Major topic |
| Alleles | |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Cell Division | |
| Chromosome Mapping | |
| Gene Deletion | |
| Gene Expression | |
| Genetic Markers | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Mutation | |
| Neoplasm Transplantation | |
| Signal Transduction | |
| Smad4 Protein | |
| Transforming Growth Factor beta | |
| Transplantation, Heterologous | |
| Tumor Cells, Cultured |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA62924 | NCI NIH HHS | United States | P50CA062924 | PubMed and NIH |
Source NIH RePORTER
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 8553063 | New tumor suppressor found in pancreatic cancer. | https://conductscience.org/library/papers/8553063 |
Source PubMed
Cited by743
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,111 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42888424 | PAFAH1B1 stabilization, through PUM2-mediated competitive binding with miRNAs on its' 3'-UTR, takes active actions on ferroptosis to overcome the radioresistance to 125I radioactive particles of pancreatic ductal adenocarcinoma. | J Transl Med | 2026 | https://conductscience.org/library/papers/42888424 | PubMed |
| 42631853 | Pancreatic ductal adenocarcinoma and its subtypes: clinical relevance of histopathology and molecular characterization, integrating the key updates of the 2026 WHO classification. | Virchows Arch | 2026 | https://conductscience.org/library/papers/42631853 | PubMed |
| 42581019 | SMAD4 Expression and Its Association With Treatment Resistance and Clinical Outcomes in Oral Squamous Cell Carcinoma Treated With Preoperative Chemoradiotherapy. | Cancer Rep (Hoboken) | 2026 | https://conductscience.org/library/papers/42581019 | PubMed |
| 42294061 | Signaling pathway mechanisms in pancreatic ductal adenocarcinoma tumor microenvironment and emerging targeting strategies for improved prognosis. | Oncol Rev | 2026 | https://conductscience.org/library/papers/42294061 | PubMed |
| 42122213 | Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy in Patients with Early-Onset Pancreatic Cancer: Clinical Outcomes and Toxicity. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122213 | PubMed |
| 42121938 | A Deep Dive into the Molecular and Immune Landscape of Undifferentiated Carcinomas with Osteoclast-like Giant Cells. | Cells | 2026 | https://conductscience.org/library/papers/42121938 | PubMed |
| 42039629 | Increased expression of a subset of genes within reduced copy number regions across multiple cancer types. | bioRxiv | 2026 | https://conductscience.org/library/papers/42039629 | PubMed |
| 42032062 | Identification of TMEM115 as a tumor suppressor gene and clinical prognostic factor that influences TERT expression in pancreatic cancer. | Sci Rep | 2026 | https://conductscience.org/library/papers/42032062 | PubMed |
| 42014683 | TGF-β/SMAD4/14-3-3σ/TFEB axis promotes mesenchymal-epithelial transition and inhibits autophagy in colorectal cancer. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/42014683 | PubMed |
| 41827913 | TGF-β Signaling as a Pathological Continuum Linking Idiopathic Pulmonary Fibrosis and Lung Cancer. | Cells | 2026 | https://conductscience.org/library/papers/41827913 | PubMed |
| 41813780 | Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing. | Sci Rep | 2026 | https://conductscience.org/library/papers/41813780 | PubMed |
| 41742159 | Prognostic impact of pancreatic intraepithelial neoplasia at the resection margin in pancreas cancer. | BMC Surg | 2026 | https://conductscience.org/library/papers/41742159 | PubMed |
| 41650466 | Convergence for Inactivation of TGFβ Signaling Is a Common Feature of Advanced Pancreatic Cancer. | Cancer Discov | 2026 | https://conductscience.org/library/papers/41650466 | PubMed |
| 41555381 | Etiology of polyploid giant cancer cells: a new frontier in cancer biology. | Cancer Cell Int | 2026 | https://conductscience.org/library/papers/41555381 | PubMed |
| 41375051 | Pancreatic Cancer Organoids: Modeling Disease and Guiding Therapy. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41375051 | PubMed |
| 41270189 | GPR25 promotes the formation of lung and liver tissue-resident memory CD8 T cells. | Sci Immunol | 2025 | https://conductscience.org/library/papers/41270189 | PubMed |
| 41073669 | Primary tumor chromatin landscape governs metastatic organotropism. | Nat Cancer | 2025 | https://conductscience.org/library/papers/41073669 | PubMed |
| 40584902 | Regulation of ubiquitin-proteasome system and its relative pathways in pancreatic adenocarcinoma. | Bioimpacts | 2025 | https://conductscience.org/library/papers/40584902 | PubMed |
| 40430535 | Medicinal Chemistry Strategies in Targeting TGF-βR1 Kinase Domain: Unveiling Insights into Inhibitor Structure-Activity Relationship (SAR). | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40430535 | PubMed |
| 40427100 | Long Non-Coding RNAs and RNA-Binding Proteins in Pancreatic Cancer Development and Progression. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427100 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SMAD4 | 4089 | Swiss-Prot's references | https://conductscience.org/library/genes/4089 | NCBI Gene |
| DCC | 1630 | PubTator's text mining | https://conductscience.org/library/genes/1630 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
Data11
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8553070
GET https://conductscience.org/api/papers/v1/8553070/cited_by?page=2